reports
Prospect Capital Corp: 2 directors
Two Directors at Prospect Capital Corp bought 240,900 shares at between 4.240USD and 4.278USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
NNN Reit Inc: 1 director
A director at NNN Reit Inc sold 55,356 shares at 42.460USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
B2Gold Completes Phase 2 Expansion of Fekola Solar Plant in Mali
B2Gold Completes Phase 2 Expansion of Fekola Solar Plant in Mali VANCOUVER, British Columbia, March 18, 2025 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) is pleased to announce the Phase 2 expansion of the Fekola Solar Plant is complete and operational. B2Gold commenced construction of the Phase 2 Solar Plant expansion in June 2023 with initial land clearing and road construction, and ramped up to physical equipment construction in February 2024. The expansion of the Fekola Solar Plant was completed in the fourth quarter of 2024 an...
LexinFintech Holdings Ltd. Reports Fourth Quarter and Full Year 2024 U...
LexinFintech Holdings Ltd. Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results SHENZHEN, China, March 18, 2025 (GLOBE NEWSWIRE) -- LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading technology-empowered personal financial service enabler in China, today announced its unaudited financial results for the quarter ended December 31, 2024. Mr. Jay Wenjie Xiao, Chairman and Chief Executive Officer of Lexin, commented, “The company remains committed to its prudent operating strategy and has achieved solid progress in its transformation, with key ...
Pricing of CNH Industrial Capital LLC $500 million notes
Pricing of CNH Industrial Capital LLC $500 million notes Basildon, March 18, 2025 CNH Industrial N.V. (NYSE: CNH) today announced that its wholly owned subsidiary, CNH Industrial Capital LLC, has priced $500 million in aggregate principal amount of 4.750% notes due 2028, with an issue price of 99.658%. The offering is expected to close on March 21, 2025, subject to the satisfaction of customary closing conditions. CNH Industrial Capital LLC intends to add the net proceeds from the offering to its general funds and use them for working capital and other general corporate purposes, includi...
PTC Therapeutics Inc: 1 director
A director at PTC Therapeutics Inc sold 11,220 shares at 56.159USD and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Atlassian Corp: 2 directors
Two Directors at Atlassian Corp sold 15,896 shares at between 220.771USD and 220.772USD. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
Clarivate Plc: 1 director
A director at Clarivate Plc bought 237,176 shares at 4.170USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Westrock Coffee Co: 1 director
A director at Westrock Coffee Co bought 150,000 shares at 6.824USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Armand « Mondo » Duplantis, star du saut à la perche, vise un record d...
HERZOGENAURACH, Allemagne--(BUSINESS WIRE)-- Armand « Mondo » Duplantis, détenteur du record du monde de saut à la perche, pense pouvoir porter le record du monde de saut à la perche à 6,40 mètres dans les prochaines années, a déclaré l'athlète lors d'un entretien avec Arne Freundt, PDG de PUMA, publié dans le cadre du rapport annuel de l'entreprise sportive. Ce communiqué de presse contient des éléments multimédias. Voir le communiqué complet ici : En ce qui concerne le saut à la perche, Mondo est dans une ligue à part. En effet, il a remporté deux médailles d'or olympiques, deux championnat...
American Financial Group Inc: 1 director
A director at American Financial Group Inc sold 2,542 shares at 125.665USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
Coterra Energy Inc: 2 directors
Two Directors at Coterra Energy Inc sold 98,000 shares at between 28.132USD and 28.765USD. The significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...
Abbvie Inc: 1 director
A director at Abbvie Inc sold 17,644 shares at 212.340USD and the significance rating of the trade was 87/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of American Homes 4 Rent and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 13 March 2025 in which we reassessed the appropriateness of the ratings in the contex...
Micron Technology Inc: 1 director
A director at Micron Technology Inc sold 6,525 shares at 100.000USD and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Verisk Analytics Inc: 2 directors
Two Directors at Verisk Analytics Inc sold 2,500 shares at between 287.830USD and 288.495USD. The significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
Moody's Ratings revises Dentsply Sirona's outlook to negative; affirms...
Moody's Ratings (Moody's) revised Dentsply Sirona Inc.'s ("Dentsply Sirona") outlook to negative from stable. At the same time, we affirmed Dentsply Sirona's Baa2 issuer rating, Baa2 senior unsecured rating and Prime-2 commercial paper rating. The revision of the outlook to negative reflects our v...
CEMATRIX To Report Fourth Quarter and 2024 Year End Results on March 2...
CEMATRIX To Report Fourth Quarter and 2024 Year End Results on March 26, 2025 Earnings Webinar Scheduled for 1:00 p.m. ET, March 27, 2025 CALGARY, Alberta, March 18, 2025 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSX: CEMX) (OTCQB:CTXXF) ("CEMATRIX" or the "Company"), a specialty construction contractor that produces cellular concrete solutions on site and is a leading manufacturer and supplier of cellular concrete in North America today announced that it will release its consolidated financial results for the fourth quarter and year ended December 31, 2024, after the market closes on M...
Moody's Ratings upgrades the rating of the City of Athens to Baa3 and ...
Moody's Ratings (Moody's) has today upgraded the local and foreign currency long-term issuer ratings of the City of Athens ("Athens") to Baa3 from Ba1, and changed the outlook to stable from positive. The city's Baseline Credit Assessment (BCA) was also upgraded by one notch to baa3 from ba1. This...
Oragenics, Inc. Announces Filing of 2024 Annual Report on Form 10-K
Oragenics, Inc. Announces Filing of 2024 Annual Report on Form 10-K SARASOTA, Fla., March 18, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and brain-related health conditions, today announced the filing of its Annual Report on Form 10-K for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission on March 14, 2025. The Company’s audited consolidated financial statements received an unqualified audit opinion from its independent registered public accounting firm. As part of ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.